A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia

被引：0
|
作者：
Kocyigit, Y. [1 ]
Ayhan, Y. [1 ]
Yoca, G. [1 ]
Karahan, S. [2 ]
Yazici, M. K. [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Psychiat, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70767-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.044
引用
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia
    Tugal, O
    Yazici, KM
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S295 - S295
  • [2] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia
    Tugal, O
    Yazici, KM
    Yagcioglu, AEA
    Gogus, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (02): : 117 - 123
  • [3] L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled Trial
    Ralph, Anna P.
    Waramori, Govert
    Pontororing, Gysje J.
    Kenangalem, Enny
    Wiguna, Andri
    Tjitra, Emiliana
    Sandjaja
    Lolong, Dina B.
    Yeo, Tsin W.
    Chatfield, Mark D.
    Soemanto, Retno K.
    Bastian, Ivan
    Lumb, Richard
    Maguire, Graeme P.
    Eisman, John
    Price, Ric N.
    Morris, Peter S.
    Kelly, Paul M.
    Anstey, Nicholas M.
    [J]. PLOS ONE, 2013, 8 (08):
  • [4] A 10-WEEK, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL OF ADJUNCTIVE MODAFINIL FOR NEUROCOGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA
    Letourneau, Karine
    Demers, M. F.
    Simard, M.
    Emond, C.
    Roy, M. A.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 283 - 283
  • [5] A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia
    Fadaii, F.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S131 - S132
  • [6] A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia
    Niknam, Z.
    Fadaii, F.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S280 - S281
  • [7] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Roeske, Maxwell J.
    Mchugo, Maureen
    Rogers, Baxter
    Armstrong, Kristan
    Avery, Suzanne
    Donahue, Manus
    Heckers, Stephan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2024, 49 (04) : 681 - 689
  • [8] Modulation of Hippocampal Hyperactivity in Schizophrenia With Levetiracetam: a Randomized, Double-Blind, Cross-Over, Placebo-Controlled Trial
    Roeske, Maxwell
    McHugo, Maureen
    Rogers, Baxter
    Avery, Suzanne
    Armstrong, Kristan
    Heckers, Stephan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 350 - 351
  • [9] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Maxwell J. Roeske
    Maureen McHugo
    Baxter Rogers
    Kristan Armstrong
    Suzanne Avery
    Manus Donahue
    Stephan Heckers
    [J]. Neuropsychopharmacology, 2024, 49 : 681 - 689
  • [10] A double-blind, dose-ranging, placebo-controlled trial of L-arginine for PAD
    Oka, RK
    Szuba, A
    Giacomini, JC
    Kapoor, O
    Soltani, A
    Bene, G
    Cooke, JP
    [J]. CIRCULATION, 2002, 106 (19) : 741 - 741
12345